DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c60257) has announced the addition of Datamonitor's new report: Sanofi-Aventis - SWOT Analysis to their offering.
CHICAGO -- Many value investors look for stocks trading at Price/Earnings multiples below 15 and Price/Book multiples below 3. Combining these valuation measures with a Zacks Rank of #1 ("Strong Buy") or #2 ("Buy") helps to ensure that a stock is truly undervalued. The High Rank Value Profit Track strategy...
CHICAGO -- Many value investors look for stocks trading at Price/Earnings multiples below 15 and Price/Book multiples below 3. Combining these valuation measures with a Zacks Rank of #1 ("Strong Buy") or #2 ("Buy") helps to ensure that a stock is truly undervalued. The High Rank Value Profit Track strategy...
LYON, France -- Reportlinker.com announces that a new market research report related to the worldwide neurology industry is now available to its catalogue.
NEW YORK, Nov. 11 /PRNewswire/ -- Cynvec LLC, a privately-held biopharmaceutical company focused on developing novel cancer therapies that harness the apoptotic ability of the Sindbis viral vector, announced today that it has appointed Frank D. Stonebanks President and Chief Executive Officer, effective immediately, to lead the company's next...
Pharmaceutical firm Sanofi-Aventis, Bridgewater, NJ, has announced that Chris Viehbacher, a former Glaxo-Smithkline executive, will succeed Gerard Le Fur as CEO on Dec. 1st. Under Mr. Viehbacher, Sanofi-Aventis will attempt to diversify its activities by investing in dietary supplements. One of the new CEO's missions will be to multiply acquisitions...
CHICAGO, Sept. 10 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks. Seven Summits Strategic Investments' PriceWatch Alerts are available at http://www.iotogo.com/s/091008A (Note: You may have to copy this link into your browser then press the [ENTER] key.) Today's PriceWatch Alerts...
PARIS, September 10 /PRNewswire-FirstCall/ -- - Abstracts 185 and 1112 Sanofi-aventis, a world leader in diabetes care, announced results from two randomized clinical studies presented at the European Association for the Study of Diabetes EASD 44th Annual Meeting demonstrating that the "basal plus" insulin strategy with LANTUSR...
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/8c1471/the_top_10_worlds) has announced the addition of the "The Top 10 World's Leading Pharmaceutical Companies: Sanofi-Aventis" report to their offering. In a highly dynamic and fragmented pharmaceutical market, besieged by intense competition, rapid pace of technological innovations and the uncertainty regarding future government...
KNOXVILLE, Tenn. -- Chris Bevil has been named vice president of sales for Varsity Sports Media VSM. Bevil will be based in Knoxville, where he will be responsible for all sales management duties for VSM, and will work closely with Craig Baroncelli, VSM general manager and publisher, on marketing strategies...
GETTING your brand noticed early in its lifespan is crucial to pharma product position strategy said, Corinne Le Goff, VP, marketing, at Sanofi-Aventis. "The most money we can make at the beginning, the better," Le Goff said at the Center for Business Intelligence's 3rd Annual Pharmaceutical Market Research Summit...
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c82915) has announced the addition of "Triple Analysis: Decoding Big Pharma's R&D Strategy in Oncology and Special Focus on Leukemias and Lymphomas" to their offering This is the report for professionals interested to grasp big pharma's R&D strategy in oncology and at...
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c82813) has announced the addition of Triple Analysis: Decoding Big Pharma's R&D Strategy in Oncology and Special Focus Lung Cancer and Melanoma to their offering. This is the report for professionals interested to grasp big pharma's R&D strategy in oncology and at...
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c82790) has announced the addition of "Triple Analysis: Decoding Big Pharma's R&D Strategy In Oncology and Special Focus on Breast and Prostate Cancer" to their offering. This is the report for professionals interested to grasp big pharma's R&D strategy in oncology and...
Big pharmas might be down, but looking at their drugs pipelines, they are certainly not out. Richard Hemming French pharmaceutical company Sanofi-Aventis'sbetter-than-expected fourth-quarter profit increase of 6.2 per cent and subsequent share price rally contrasts sharply with declining profits and recent prolonged...
SANOFI Pasteur named Wayne Pisano president and CEO, replacing David Williams, who is retiring. He reports to SanofiAventis CEO Gerard Le Fur. Pisano was previously SVP, global commercial operations and corporate strategy, tasked with directing the development and implementation of the company's commercial strategy. He joined the company...
NEW YORK & PHILADELPHIA -- While pharmaceutical firms including Pfizer and AstraZeneca have recently announced plans to increase outsourcing of manufacturing to Asia in cost-cutting measures, ALM's Strategic Research Institute announces an important conference on Global Biopharmaceutical Outsourcing, February 25-26, 2008 in Philadelphia, Pa. The two-day conference focuses...
NEW YORK -- ALM's Strategic Research Institute is proud to present, Positioning Pharmaceutical Brands for Maximum Value being held February 25-26, 2008 at The Loews Philadelphia Hotel in Philadelphia, PA. Featuring presentations by distinguished brand leaders from Johnson & Johnson Company, TAP Pharmaceutical Products, Inc., AstraZeneca, Sanofi-Aventis, Abbott...
LONDON, December 5 /PRNewswire/ -- - Forecasting key to decision making and business strategies - Challenges to define forecast measures against diversity in geography and varied time horizons - Senior Forecasting executives from companies such as Novartis,...
NEW YORK -- Heartbeat Digital has added four major pharma and biotech companies to its client list, according to Bill Drummy, CEO and Chairman of the Manhattan-based company. These four new clients represent diverse categories within healthcare: Oncology, Women's Health, Depression Treatment and Cardiovascular Health. They join Heartbeat's...
Articles 2007-11-19
<< Previous
page 1 of 1
Next >>
Premier Vendor Content
Whitepapers, webcasts & resources from our Power Center Sponsors
Powerful, Dell is built to fit your business needs Customized systems, experts trained in small business, 24/7/365 support, and powerful, reliable technology. Dell, big results for small business.
